Overview

Covid 19 has brought in a major boom in the global diagnostics industry. The diagnostic firms are accruing benefits from increased testing, which is helping them drive revenues. Diagnostic companies continue to see a sharp rally in their stock prices. These firms are accruing benefits from rising testing revenue. While covid-19 testing helped drive revenues, non-covid revenues continued to rise at clinics and hospitals.

The companies also have adapted to new norms of rising home sample collections and testing. However, India has some lessons to take too. Experts opine that the Indian Diagnostics Industry needs to be better prepared for such challenging times. Home Diagnostics is going to be bigger than ever, like telemedicine. Technology-led diagnostics will pave way for improved customer experience. Upgradation of lab infrastructure and accreditations needs to be more promptly done. The opportunities are immense and so are the challenges.

This phygital event will explore the future of digital diagnostics, the scaling up of diagnostics facilities, and the importance of new-age tests.

Who Should & Will Attend?

Flowers

Key Highlights

  • 50+ Speakers

  • 10+ Panel
    Discussions

  • 300+
    Delegates

  • 8+ Networking
    Hours

 

Contact Us

For Partnership & Speaking Opportunities

Register Now